TD Cowen maintains Buy on Tilray Brands, cuts target to $5
TD Cowen analyst Robert Moskow maintains a Buy rating on Tilray Brands but lowers the price target from $7 to $5, reflecting revised valuation expectations.

*this image is generated using AI for illustrative purposes only.
TD Cowen analyst Robert Moskow has maintained a Buy rating on Tilray Brands while lowering the price target to $5 from $7. The revised target indicates a shift in the firm's valuation expectations for the cannabis company's stock.
Rating and Price Target Adjustment
The decision to retain the Buy rating suggests continued confidence in Tilray Brands' long-term prospects despite the reduced price objective. The new target of $5 represents a decrease from the previous estimate of $7.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $7 |
| New Price Target | $5 |
The adjustment comes as market conditions and company performance metrics are reassessed by the financial institution.
What specific market conditions or performance metrics prompted TD Cowen to lower the price target?
How might this price target adjustment influence investor sentiment toward Tilray Brands in the short term?
What are the key catalysts that could drive Tilray's stock back toward or beyond the previous $7 target?































